Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism RYR2 inhibitors(Ryanodine receptor 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H30N2O3 |
InChIKeySRNQVUHNADNHLL-UHFFFAOYSA-N |
CAS Registry714906-29-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Polymorphic Catecholergic Ventricular Tachycardia | Preclinical | US | 01 Apr 2018 |